Diagnostics & Pathology in India

Increasing health consciousness and preventive care have changed the landscape of healthcare services market in more ways than one. Whether it is wellness checkups, preventive care checkups or insurance-related checkups, diagnostics and pathology laboratories are growing significantly, fuelled by the growth in outsourcing diagnostics tests and clinical research. The Indian diagnostic and pathological labs test services market was valued at Rs66.87 billion in FY2008.

Scope Of The Report

In this innovative report, it covers basic trends in diagnostic & pathology industry. A brief market overview of diagnostic and healthcare market is been analysed including global, Indian market scenario and major markets.

• The report analyses the facts regarding the accreditions & quality control aspects in diagnostics and pathology market.
• It presents the growth drivers for healthcare industry with reference to healthcare institutes and services.
• It provides issues & challenges involved in healthcare industry. o It provides information on the critical success factors with reference to automation & standardization, Laboratory accreditation etc.
• 6 Major players and have been profiled providing introduction, financial, operational, business strategy & competitive advantages, infrastructure accreditations of the company.
• The report provides a future outlook of diagnostic & pathology market. The major players in diagnostics and pathological test labs market are Metropolis, Religare SRL Diagnostics, Dr Lal's Pathology, Piramal Diagnostics (formerly Wellspring), Thyrocare and Anand Labs.

• 1. Industry & Market Overview

  • 1.1 Global medical and diagnostics laboratory
  • 1.2 Indian healthcare industry
    • 1.2.1 Market Size and Growth
    • 1.2.2 Healthcare infrastructure
    • 1.2.3 Overview of diagnostics & pathology laboratory industry
    • 1.2.4 Existing Business Models

• 2. Accreditations & Quality Control

  • 2.1 Introduction
  • 2.2 National Accreditation Board for Testing & Calibration Laboratories
  • 2.3 College for American Pathologist
    • 2.3.1 Benefits of CAP Accreditation
  • 2.4 Effect of the accreditation process among the clinical labs
    • 2.4.1 Quality manual
    • 2.4.2 Quality System Procedure
    • 2.4.3 Standard Test Operating Procedure (SOP)
    • 2.4.4 Records
    • 2.4.5. Quality control (Interlab/external)
    • 2.4.6. Internal audit
    • 2.4.7. Overall cost/expenses for Audit

• 3. Major Players

  • 3.1 Introduction
  • 3.2 Metropolis Health Services (India) Ltd.
    • 3.2.1. Company Background
    • 3.2.2. Contact Address
    • 3.2.3 Management Team
    • 3.2.4. Infrastructure & Accreditations
    • 3.2.5. Business Strategy & Competitive Advantages
    • 3.2.6. Outlook
  • 3.3 Religare SRL Diagnostics
    • 3.3.1. Company Background
    • 3.3.2. Contact Address
    • 3.3.3. Management Team
    • 3.3.4. Infrastructure & Accreditations
    • 3.3.5. Business Strategy & Competitive Advantages
    • 3.3.6. Outlook
  • 3.4 Piramal Diagnostics Services Pvt. Ltd. (PDSL)
    • 3.4.1. Company Background
    • 3.4.2. Contact Address:
    • 3.4.3. Management Team
    • 3.4.4. Infrastructure & Accreditations
    • 3.4.5. Business Strategy & Competitive Advantages
    • 3.4.6. Outlook
  • 3.5 Dr Lal Pathlabs
    • 3.5.1. Company Background
    • 3.5.2. Contact Address
    • 3.5.3. Management Team
    • 3.5.4. Infrastructure & Accreditations
    • 3.5.5. Business Strategy & Competitive Advantages
    • 3.5.6. Outlook
  • 3.6 Thyrocare
    • 3.6.1. Company Background
    • 3.6.2. Contact Address
    • 3.6.3. Management Team
    • 3.6.4. Infrastructure & Accreditations
    • 3.6.5. Business Strategy & Competitive Advantages
    • 3.6.6. Outlook
  • 3.7 Anand Labs
    • 3.7.1. Company Background
    • 3.7.2. Contact Address
    • 3.7.3. Management Team
    • 3.7.4. Infrastructure & ccreditations
    • 3.7.5. Business Strategy & Competitive Advantages
    • 3.7.6 Outlook
  • 3.8 Quest Diagnostics India Pvt. Ltd.
    • 3.8.1. Company Background
    • 3.8.2. Contact Address
    • 3.8.3. Management Team
    • 3.8.4. Infrastructure & Accreditations
    • 3.8.5. Business Strategy & Competitive Advantages
    • 3.8.6. Outlook

• 4. Growth Drivers

  • 4.1 Introduction
  • 4.2 Healthcare Institutes
    • 4.2.1 Foreign hospitals outsourcing diagnostics tests
    • 4.2.2 Polyclinics
    • 4.2.3 Pharmacies
    • 4.2.4 Medical KPO
  • 4.3 Healthcare Services
    • 4.3.1 CRO
    • 4.3.2 Molecular diagnostics
    • 4.3.3 Pharmacogenomics
  • 4.4 Theranostics, driving diagnostic test in drug development
  • 4.5 Logistics and Infrastructure
  • 4.6 IT Infrastructure and Network
  • 4.7 Insurance

• 5. Critical Success Factors

  • 5.1 Automation and standardisation
  • 5.2 Success of tests
  • 5.3 Processing blood samples
  • 5.4 Laboratory accreditation

• 6. Issues and Challenges

  • 6.1 Regulatory issues
  • 6.2 Reimbursement pressures
  • 6.3 Analytical and quality issues
  • 6.4 Accreditation procurement

• 7. Recent Trends

  • 7.1 Diagnostics Majors Mull over Outsourced Path Lab Management
  • 7.2 Consolidation in Diagnostics Services
  • 7.3 Diagnostics and Pathology Market Set to Flourish

• 8. Future Outlook

• Annexures

  • Annexure I Bibliography
  • Annexure II Glossary

• List of Tables

  • Table 1.1: Molecular Diagnostics Technologies
  • Table 1.2 Public healthcare physical infrastructure

• List of Figures

  • Figure 2.1: Indian Healthcare Market Size (FY03-FY08)
  • Figure 2.2: Healthcare Expenditure (2007)
  • Figure 2.3: Medical Devices & Diagnostics Market (2008)
  • Figure 2.4: Indian Diagnostics & Pathology Test Market (2005-2008)
  • Figure 2.5: Structure of Diagnostics & Pathology Labs Industry
  • Figure 2.6: Indian Diagnostics and Pathology Market (2008)
  • Figure 2.7: Indian Diagnostics and Pathological Test Market by Therapeutic Segment 2008
  • Figure 2.8: Referral Lab business model
  • Figure 8.1: Indian Diagnostic and Path Labs Market Forecast (2008-13)